Design of study & Patients:
The study group included 150 consecutive patients with diagnosed GD who subsequently underwent surgery. The patients were divided into two groups according to whether the pre-operative ultrasound scan showed diffuse parenchyma (group 1; n=70) or nodules (group 2; n=80).
Results:
Of the 150 patients, 18 (12%) were found to have papillary thyroid carcinoma. Papillary carcinoma was found in seven patients (10%) in group 1 and 11 patients (13.7%) in group 2. After evaluating the overall groups, the incidence of carcinoma in the parenchyma outside a nodule was 67%, whereas the incidence of carcinoma in a nodule was 33%.
Conclusions: Carcinoma can occur in Graves' disease patients without nodules, and the absence of nodules on ultrasonography examination does not eliminate the risk of malignancy.
COMMENT
The incidence of nodularity in patients with Graves' disease (GD) varies between 22-45%, i.e. 3-4-fold higher than in the normal population. The incidence of malignancy in such nodules is reported to range from <1% to almost 10%. A higher rate of malignancy in thyroid nodules associated with GD is believed to be due to the long-standing stimulation of thyrocytes by the growth-promoting effect of immunoglobulins (TSAb). Any clinical circumstance that raises chronically serum TSH levels (or in the case of GD, the TSHreceptor antibodies) is potentially capable of stimulating growth of normal thyroid cells, eventually leading to carcinomatosis. However in theory, increased thyrocyte growth should favour follicular-type cell structures (adenoma, carcinoma), while in this study all 18 tumors found were of the papillary-type (with 4 showing a follicular variant). Another disturbing particularity of present results was that a high rate of carcinomas was also found in the group of patients without ultrasonographically demonstrated nodules. These tumors seemed quite aggressive, with thyroid capsule & vascular invasion (9/18 cases) and microscopic extrathyroid invasion (6/18 cases). These histo-pathological characteristics may seem even more surprising when considering the small size of these lesions (2-9 mm in 15/18 cases, 12-20 mm in 3/18 cases), clearly indicating that most cases were micro-carcinomas.
Many questions, unfortunately, remain unanswered. Are we dealing with a particular risk for these Turkish patients, perhaps because of long-standing GD (up to 5 years of duration)? Also, the TSHreceptor antibodies titers were quite high, on the average ~10-fold the upper limit of normality. Could this be another special feature to explain the unusually high rate of malignancy?
And finally, are there additional factors to consider, such as iodine deficiency in the region? (Daniel Glinoer, M.D.; Ph.D.)
See Table below 
